Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,033 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection who had received direct-acting antiviral therapy.
Tada T, Kurosaki M, Toyoda H, Tamaki N, Yasui Y, Nakamura S, Mori N, Tsuji K, Ochi H, Akahane T, Kobashi H, Fujii H, Marusawa H, Kondo M, Urawa N, Yoshida H, Uchida Y, Morita A, Hasebe C, Mitsuda A, Ogawa C, Narita R, Kubotsu Y, Matsushita T, Shigeno M, Okamoto E, Okada K, Kasai T, Ishii T, Nonogi M, Yasuda S, Koshiyama Y, Kumada T, Izumi N. Tada T, et al. Among authors: fujii h. Liver Int. 2024 Nov;44(11):3060-3071. doi: 10.1111/liv.16093. Epub 2024 Sep 2. Liver Int. 2024. PMID: 39223936
Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma.
Tamaki N, Mori N, Takaki S, Tsuji K, Tada T, Nakamura S, Ochi H, Mashiba T, Doisaki M, Marusawa H, Kobashi H, Fujii H, Ogawa C, Nonogi M, Arai H, Uchida Y, Urawa N, Narita R, Akahane T, Kondo M, Yasui Y, Tsuchiya K, Izumi N, Kurosaki M. Tamaki N, et al. Among authors: fujii h. Anticancer Res. 2024 Sep;44(9):3913-3918. doi: 10.21873/anticanres.17219. Anticancer Res. 2024. PMID: 39197893
Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma.
Mori N, Tamaki N, Takaki S, Tsuji K, Tada T, Nakamura S, Ochi H, Mashiba T, Doisaki M, Marusawa H, Kobashi H, Fujii H, Ogawa C, Nonogi M, Arai H, Uchida Y, Urawa N, Narita R, Akahane T, Kondo M, Yasui Y, Tsuchiya K, Izumi N, Kurosaki M. Mori N, et al. Among authors: fujii h. Invest New Drugs. 2024 Aug 30. doi: 10.1007/s10637-024-01470-y. Online ahead of print. Invest New Drugs. 2024. PMID: 39212893
Safety/efficacy of atezolizumab + bevacizumab during anti-platelet/anticoagulation therapy in unresectable hepatocellular carcinoma.
Moriguchi M, Okuda K, Horiguchi G, Kataoka S, Seko Y, Yamaguchi K, Nishimura T, Fujii H, Mitsumoto Y, Miyagawa M, Kirishima T, Okishio S, Hara T, Ishikawa H, Nagao Y, Jo M, Ishii M, Tanaka S, Yamauchi N, Mitsuyoshi H, Nakajima T, Taketani H, Yano K, Arai M, Umemura A, Itoh Y. Moriguchi M, et al. Among authors: fujii h. Liver Int. 2024 Aug;44(8):1751-1761. doi: 10.1111/liv.15918. Epub 2024 Jun 4. Liver Int. 2024. PMID: 38838097
A case of disseminated peritoneal metastases after 2-year conservative treatment for intramucosal colon carcinoma due to a perforation during endoscopic submucosal dissection.
Nakatsugawa Y, Okuyama Y, Fukui A, Tanaka M, Inada Y, Nishimura T, Fujii H, Tomatsuri N, Sato H, Urata Y. Nakatsugawa Y, et al. Among authors: fujii h. Clin J Gastroenterol. 2024 Jun;17(3):441-446. doi: 10.1007/s12328-024-01925-y. Epub 2024 Feb 18. Clin J Gastroenterol. 2024. PMID: 38368579
Wide surgical margins may be necessary to reduce recurrence and mortality in patients with localized periosteal chondrosarcoma: retrospective analysis of twenty three patients and literature meta-analysis.
Masunaga T, Tsukamoto S, Honoki K, Fujii H, Tanaka Y, Ishida Y, Tanaka Y, Mavrogenis A, Errani C, Kawai A. Masunaga T, et al. Among authors: fujii h. Int Orthop. 2024 Nov 21. doi: 10.1007/s00264-024-06371-6. Online ahead of print. Int Orthop. 2024. PMID: 39570338
Deep-learning-driven optical coherence tomography analysis for cardiovascular outcome prediction in patients with acute coronary syndrome.
Hamana T, Nishimori M, Shibata S, Kawamori H, Toba T, Hiromasa T, Kakizaki S, Sasaki S, Fujii H, Osumi Y, Iwane S, Yamamoto T, Naniwa S, Sakamoto Y, Fukuishi Y, Matsuhama K, Tsunamoto H, Okamoto H, Higuchi K, Kitagawa T, Shinohara M, Kuroda K, Iwasaki M, Kozuki A, Shite J, Takaya T, Hirata KI, Otake H. Hamana T, et al. Among authors: fujii h. Eur Heart J Digit Health. 2024 Sep 27;5(6):692-701. doi: 10.1093/ehjdh/ztae067. eCollection 2024 Nov. Eur Heart J Digit Health. 2024. PMID: 39563910 Free PMC article.
4,033 results